Department of Research, Olmsted Medical Center, Rochester, Minnesota
Department of Research, Olmsted Medical Center, Rochester, Minnesota.
Ann Fam Med. 2018 Mar;16(2):100-110. doi: 10.1370/afm.2179.
The purpose of this study was to assess patient and practice outcomes after introducing the Asthma APGAR (Activities, Persistent, triGGers, Asthma medications, Response to therapy) tools into primary care practices.
We used a pragmatic cluster-randomized controlled design in 18 US family medicine and pediatric practices to compare outcomes in patients with persistent asthma aged 5 to 45 years after introduction of the Asthma APGAR tools vs usual care. Patient outcomes included asthma control, quality of life, and emergency department (ED), urgent care, and inpatient hospital visits. The practice outcome was adherence to asthma guidelines.
We enrolled 1,066 patients: 245 children, 174 adolescents, and 647 adults. Sixty-five percent (692 patients) completed both baseline and 12-month questionnaires, allowing analysis for patient-reported outcomes. Electronic health record data were available for 1,063 patients (99.7%) for practice outcomes. The proportion of patients reporting an asthma-related ED, urgent care, or hospital visit in the final 6 months of the study was lower in the APGAR practices vs usual care practices (10.6% vs 20.9%, = .004). The percentage of patients with "in control" asthma increased more between baseline and 1 year in the APGAR group vs usual care group (13.5% vs 3.4%, =.0001 vs =.86) with a trend toward better control scores and asthma-related quality of life in the former at 1 year ( ≤.06 and = .06, respectively). APGAR practices improved their adherence to 3 or more guideline elements compared with usual care practices (20.7% increase vs 1.9% decrease, = .001).
Introduction of the Asthma APGAR tools improves rates of asthma control; reduces asthma-related ED, urgent care, and hospital visits; and increases practices' adherence to asthma management guidelines.
本研究旨在评估在初级保健实践中引入哮喘 APGAR(活动、持续、触发因素、哮喘药物、治疗反应)工具后患者和实践的结果。
我们在美国 18 家家庭医学和儿科实践中使用了一种实用的聚类随机对照设计,比较了引入哮喘 APGAR 工具后 5 至 45 岁持续哮喘患者的患者结局与常规护理的结局。患者结局包括哮喘控制、生活质量以及急诊部(ED)、紧急护理和住院就诊。实践结局是对哮喘指南的依从性。
我们纳入了 1066 名患者:245 名儿童,174 名青少年和 647 名成年人。65%(692 名患者)完成了基线和 12 个月的问卷,可进行患者报告的结局分析。1063 名患者(99.7%)有电子健康记录数据可用于实践结局。在研究的最后 6 个月,APGAR 实践中报告与哮喘相关的 ED、紧急护理或住院就诊的患者比例低于常规护理实践(10.6%比 20.9%, =.004)。APGAR 组与常规护理组相比,在基线和 1 年之间,“控制良好”的哮喘患者比例增加更多(13.5%比 3.4%, =.0001比 =.86),前者在 1 年时的哮喘控制评分和哮喘相关生活质量呈上升趋势(分别为 ≤.06 和 =.06)。与常规护理实践相比,APGAR 实践增加了对 3 个或更多指南要素的依从性(增加 20.7%,减少 1.9%, =.001)。
引入哮喘 APGAR 工具可提高哮喘控制率;降低与哮喘相关的 ED、紧急护理和住院就诊率;并增加实践对哮喘管理指南的依从性。